Global /United States /Financial Services /Financial Conglomerates /DMAA

Drugs Made In America Acquisition Corp.

DMAA

• NASDAQ: DMAA • Delayed

10.56USD 0%

As of 16 June 2026, Drugs Made In America Acquisition Corp. has a market cap of $356.05M USD, ranking #17500 globally and #2924 in the United States. It ranks #1874 in the Financial Services sector, and #168 in the Financial Conglomerates industry.

Global Rank

17500

Country Rank

2924

Sector Rank

1874

Industry Rank

168

Key Stats

Market Cap

$356.05MUSD

Enterprise Value

$356.05MUSD

Net Income (TTM)

$5.94MUSD

PE Ratio

56.2

Company Profile

Country (HQ)

United States

Sector

Financial Services

Industry

Financial Conglomerates

CEO

Roger Bendelac open_in_new

Founded

2024

IPO

28 Jan 2025

Website

dmaacorp.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0.2%	0.5%	1.4%	2.4%	1.8%	4.8%	6.4%	6.4%

News

DMAA Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	DMAA Drugs Made In America Acquisition Corp ISIN: KYG2847J1040 Shares Out.: Shares Outstanding: 24.277M¹ Shares Float: 19.788M² TV: TradingView: NASDAQ: DMAA SA: Stock Analysis: NASDAQ: DMAA YF: Yahoo Finance: DMAA GF: Google Finance: NASDAQ: DMAA NQ: NASDAQ: DMAA BA: Barron's: DMAA MS: Morningstar: XNAS: DMAA	10.56 USD	TV: TradingView: NASDAQ: DMAA SA: Stock Analysis: NASDAQ: DMAA YF: Yahoo Finance: DMAA GF: Google Finance: NASDAQ: DMAA NQ: NASDAQ: DMAA BA: Barron's: DMAA MS: Morningstar: XNAS: DMAA
NASDAQ MIC: XNAS	DMAAU Drugs Made In America Acquisition Corp Units (1 Ord Shs & 1 Rts) ISIN: KYG2847J1206 Shares Out.: Shares Outstanding: 23.43M¹ Shares Float: 23.43M² TV: TradingView: NASDAQ: DMAAU SA: Stock Analysis: NASDAQ: DMAAU YF: Yahoo Finance: DMAAU GF: Google Finance: NASDAQ: DMAAU NQ: NASDAQ: DMAAU BA: Barron's: DMAAU MS: Morningstar: XNAS: DMAAU	11.32 USD	TV: TradingView: NASDAQ: DMAAU SA: Stock Analysis: NASDAQ: DMAAU YF: Yahoo Finance: DMAAU GF: Google Finance: NASDAQ: DMAAU NQ: NASDAQ: DMAAU BA: Barron's: DMAAU MS: Morningstar: XNAS: DMAAU

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Drugs Made In America Acquisition Corp.

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Similar Companies

Industry: Financial Conglomerates (United States)

Name	Market Cap (USD) diff.	PE	Country
Ares Capital Corp. NASDAQ: ARCC	$13.41B 4K%	11.5	United States
Brookfield Business Corp. TSX: BBUC	$6.76B 9.46B CAD 2K%	-	United States
Blue Owl Capital Corp. NYSE: OBDC	$5.6B 1K%	9.1	United States
HA Sustainable Infrastructure Capital, Inc. NYSE: HASI	$5.22B 1K%	28.7	United States
Main Street Capital Corp. NYSE: MAIN	$4.84B 1K%	9.7	United States
Golub Capital BDC, Inc. NASDAQ: GBDC	$3.51B 886%	10.7	United States

Industry: Financial Conglomerates (Global)

Name	Market Cap (USD) diff.	PE	Country
Investor AB (publ) STO: INVE-A	$121.13B 1.14T SEK 34K%	5.9	Sweden
SK Square Co., Ltd. KRX: 402340	$72.27B 109.46T KRW 20K%	12.5	South Korea
Itaúsa S.A. BVMF: ITSA3	$30.89B 157.1B BRL 9K%	9.5	Brazil
AB Industrivärden (publ) STO: INDU-A	$22.14B 207.94B SEK 6K%	5.2	Sweden
TS Financial Holding Co., Ltd. TWSE: 2887	$18.96B 598.03B TWD 5K%	12.6	Taiwan
HAL Trust AMS: HAL	$17.85B 15.4B EUR 5K%	9.6	Netherlands

chevron_leftBack